Key stats
About GLOBAL X MARIJUANA LIFE SCIENCES IN
Home page
Inception date
Apr 4, 2017
Structure
Canadian Mutual Fund Trust (ON)
Dividend treatment
Distributes
Distribution tax treatment
Ordinary income
Income tax type
Capital Gains
Primary advisor
Global X Investments Canada, Inc.
The fund invests in equity securities as well as ADRs of companies substantially in the same proportion as its underlying index. These securities are listed on stock exchanges in North America, and are classified as life sciences companies (including those involved in biopharmaceuticals, medical manufacturing, distribution, and bio products) as well as other companies with significant business activities in the marijuana industry. Rebalanced quarterly, the portfolio is market-cap-weighted with 10% maximum capping for each constituent.
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Process Industries
Health Technology
Finance
Stocks94.35%
Process Industries36.41%
Health Technology35.63%
Finance14.78%
Technology Services2.82%
Miscellaneous1.63%
Producer Manufacturing1.26%
Distribution Services1.09%
Retail Trade0.73%
Bonds, Cash & Other5.65%
Cash5.65%
Stock breakdown by region
North America80.42%
Europe19.58%
Latin America0.00%
Asia0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows
Frequently Asked Questions
HMLSF invests in stocks. The fund's major sectors are Process Industries, with 36.41% stocks, and Health Technology, with 35.63% of the basket. The assets are mostly located in the North America region.
HMLSF top holdings are Jazz Pharmaceuticals Public Limited Company and Cronos Group Inc, occupying 18.48% and 12.45% of the portfolio correspondingly.
HMLSF last dividends amounted to 0.02 USD. The quarter before, the issuer paid 0.06 USD in dividends, which shows a 162.12% decrease.
HMLSF assets under management is 34.25 M USD. It's risen 12.24% over the last month.
HMLSF fund flows account for −10.18 M USD (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
Yes, HMLSF pays dividends to its holders with the dividend yield of 4.55%. The last dividend (Apr 7, 2025) amounted to 0.02 USD. The dividends are paid quarterly.
HMLSF shares are issued by Mirae Asset Global Investments Co., Ltd. under the brand Global X. The ETF was launched on Apr 4, 2017, and its management style is Passive.
HMLSF expense ratio is 1.01% meaning you'd have to pay 1.01% of your investment to help manage the fund.
HMLSF follows the North American Medical Marijuana Index - CAD. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
HMLSF invests in stocks.
HMLSF price has risen by 29.49% over the last month, and its yearly performance shows a −39.23% decrease. See more dynamics on HMLSF price chart.
NAV returns, another gauge of an ETF dynamics, showed a −14.18% decrease in three-month performance and has decreased by −37.74% in a year.
NAV returns, another gauge of an ETF dynamics, showed a −14.18% decrease in three-month performance and has decreased by −37.74% in a year.
HMLSF trades at a premium (0.82%) meaning the ETF is trading at a higher price than the calculated NAV.